Effect of Vaccination on Household Transmission of SARS-CoV-2: Implications for Public Health Strategies
Significant reduction in household transmission of SARS-CoV-2 is observed with one dose of vaccines, underscoring the importance of vaccination in controlling community spread and supporting public health efforts to mitigate the COVID-19 pandemic.
Februery 2022
SARS-CoV-2 Infections: Holistic Approach to Vaccines, Therapeutics, and Diagnostics
Vaccines, therapeutics, and diagnostics for SARS-CoV-2 should not be limited to the spike protein, as other viral components may also serve as viable targets for intervention, supporting a holistic approach to COVID-19 prevention and treatment strategies.
Februery 2022
SARS-CoV-2 Infection in Children and Adolescents: Epidemiology, Clinical Course, and Viral Dynamics
Review provides insights into the epidemiology, clinical course, and viral load dynamics of SARS-CoV-2 infection in children and adolescents, informing pediatric healthcare practices and public health strategies for managing the COVID-19 pandemic.
Februery 2022
Methylprednisolone vs. Dexamethasone for Severe COVID-19: Comparative Efficacy in Randomized Trial
Randomized trial demonstrates better outcomes with methylprednisolone compared to dexamethasone in patients with severe COVID-19, highlighting the potential role of alternative corticosteroids in the management of critically ill patients.
Februery 2022
Self-Inflicted Lung Injury in COVID-19 Patients: Implications of Elevated Respiratory Efforts
Impact of elevated respiratory efforts on lung function and injury in patients with COVID-19-related acute respiratory failure is investigated, shedding light on the pathophysiology of self-inflicted lung injury and guiding ventilatory management strategies in critically ill patients.
Februery 2022
Increase in Facial Paralysis during the COVID-19 Pandemic: Implications for Neurological Surveillance
High rates of spontaneous referrals of lower motor neuron palsy of the facial nerve (VII) are observed during the COVID-19 pandemic, prompting further investigation into the potential association between viral infections and facial paralysis, with implications for neurological surveillance and management.
Februery 2022
The Flu Vaccine in the COVID-19 Era: Reductions in ICU Admissions, Sepsis, and Strokes
Largest study of its kind suggests that the flu vaccine reduces ICU admissions, sepsis, and strokes, highlighting the potential benefits of influenza vaccination in reducing the burden on healthcare systems and improving patient outcomes during the COVID-19 pandemic.
Februery 2022
Effectiveness of Pfizer-BioNTech and Oxford/AstraZeneca Vaccines: Insights from Real-World Data
Large observational study from the United Kingdom demonstrates >60% protection against symptomatic COVID-19 with Pfizer-BioNTech and Oxford/AstraZeneca vaccines 28 days after one dose, supporting the effectiveness of COVID-19 vaccination in reducing disease transmission and severity.
Februery 2022
Asymptomatic SARS-CoV-2 Infections: Magnitude and Implications for Transmission Dynamics
A substantial proportion of individuals with SARS-CoV-2 infection remain asymptomatic, underscoring the importance of widespread testing and surveillance to identify and isolate asymptomatic carriers and mitigate community transmission.
January 2022
Lower Urinary Tract Symptoms in COVID-19: Understanding the Pathophysiological Mechanisms
Irritant urinary symptoms may occur irrespective of the severity of COVID-19, suggesting a multifactorial etiology and highlighting the need for comprehensive evaluation and management of lower urinary tract dysfunction in affected individuals.
January 2022
